Ex Parte Ley et al - Page 2

               Appeal 2007-2026                                                                             
               Application 10/131,772                                                                       

               to reinforce body vessels and to prevent restenosis following angioplasty in                 
               the vascular system” (Specification 1).                                                      
                      The Specification discloses stents that are configured to “limit recoil               
               and add resistance to compression . . . and provide[] increased side                         
               branch access . . .” (id. at 1-2).  For example, one embodiment “comprises a                 
               metal tube as shown in the Figure 2 end view, such as Nitinol, or stainless                  
               steel preferably, which has been etched or more preferably laser cut to [a]                  
               configuration . . . made up of a series of generally triangular-like expansion               
               cell elements” (id. at 4).                                                                   
                                              DISCUSSION                                                    
               1.  CLAIMS                                                                                   
                      Claims 33-41 are pending and on appeal.  Claims 33 and 37 are                         
               representative and read as follows:                                                          
                      Claim 33. A stent comprised of at least one cell structure                            
                      selected from the group consisting of I shaped bonate cell                            
                      structures oriented at an oblique angle relative to the                               
                      longitudinal axis of the stent, multibonate cell structures                           
                      oriented at an oblique angle relative to the longitudinal axis of                     
                      the stent and combinations thereof.                                                   
                      Claim 37. A stent comprising a plurality of bonate cell                               
                      structures wherein the bonate cell structures are I shaped, abut                      
                      one another and are disposed at an oblique angle relative to the                      
                      longitudinal axis of the stent.                                                       

                      Thus, claim 33 is directed to a stent that has at least one cell structure            
               that is an I-shaped bonate structure, a multibonate structure, or a                          
               combination of the two.  The cells must be oriented at an oblique angle                      
               relative to the longitudinal axis of the stent.                                              

                                                     2                                                      

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next

Last modified: September 9, 2013